???pagination.result.count???
Evidence for corticotropin releasing factor ( CRF) synthesis in the preoptic nucleus of Xenopus laevis tadpoles: a preliminary report based on lesion experiments. , Notenboom CD, Terlou M, Maten ML., Cell Tissue Res. June 11, 1976; 169 (1): 23-31.
Corticotropin-releasing factor ( CRF)-like immunoreactivity in the vertebrate endocrine pancreas. , Petrusz P, Merchenthaler I, Maderdrut JL, Vigh S, Schally AV., Proc Natl Acad Sci U S A. March 1, 1983; 80 (6): 1721-5.
Corticotropin-releasing factor ( CRF)-like immunoreactivity in the gastro-entero-pancreatic endocrine system. , Petrusz P, Merchenthaler I, Ordronneau P, Maderdrut JL, Vigh S, Schally AV., Peptides. January 1, 1984; 5 Suppl 1 71-8.
Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides. , Verburg-Van Kemenade BM, Jenks BG , Cruijsen PM, Dings A, Tonon MC, Vaudry H., Peptides. January 1, 1987; 8 (6): 1093-100.
Immunocytochemical localization and spatial relation to the adenohypophysis of a somatostatin-like and a corticotropin-releasing factor-like peptide in the brain of four amphibian species. , Olivereau M, Vandesande F, Boucique E, Ollevier F, Olivereau JM., Cell Tissue Res. February 1, 1987; 247 (2): 317-24.
Immunocytochemical analysis of proenkephalin-derived peptides in the amphibian hypothalamus and optic tectum. , Merchenthaler I, Maderdrut JL, Lázár G, Gulyás J, Petrusz P., Dev Biol. July 28, 1987; 416 (2): 219-27.
Functional expression of brain cholecystokinin and bombesin receptors in Xenopus oocytes. , Moriarty TM, Gillo B, Sealfon S, Roberts JL, Blitzer RD, Landau EM., Dev Biol. August 1, 1988; 464 (1): 75-9.
Activation of ionic currents in Xenopus oocytes by corticotropin-releasing peptides. , Moriarty TM, Gillo B, Sealfon S, Landau EM., Dev Biol. November 1, 1988; 464 (3): 201-5.
The CRF-related peptide sauvagine stimulates and the GABAB receptor agonist baclofen inhibits cyclic-AMP production in melanotrope cells of Xenopus laevis. , Jenks BG , van Zoest ID, de Koning HP, Leenders HJ, Roubos EW ., Life Sci. January 1, 1991; 48 (17): 1633-7.
Characterization of the genomic corticotropin-releasing factor ( CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. , Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW., Mol Endocrinol. October 1, 1992; 6 (10): 1716-24.
Xenopsin, neurotensin, neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury. , Gao GC, Wei ET., J Pharmacol Exp Ther. May 1, 1993; 265 (2): 619-25.
Spontaneous cytosolic calcium pulses in Xenopus melanotrophs are due to calcium influx during phasic increases in the calcium permeability of the cell membrane. , Shibuya I, Douglas WW., Endocrinology. May 1, 1993; 132 (5): 2176-83.
Spontaneous cytosolic calcium pulsing detected in Xenopus melanotrophs: modulation by secreto-inhibitory and stimulant ligands. , Shibuya I, Douglas WW., Endocrinology. May 1, 1993; 132 (5): 2166-75.
Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , Vamvakopoulos NC, Chrousos GP., J Clin Invest. October 1, 1993; 92 (4): 1896-902.
Immunohistochemical analysis of the relation between 5-hydroxytryptamine- and neuropeptide-immunoreactive elements in the spinal cord of an amphibian (Xenopus laevis). , Pieribone VA, Brodin L, Hökfelt T., J Comp Neurol. March 22, 1994; 341 (4): 492-506.
Immunohistochemical studies on the development of the hypothalamo-hypophysial system in Xenopus laevis. , Ogawa K, Suzuki E, Taniguchi K ., Anat Rec. February 1, 1995; 241 (2): 244-54.
Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor. , Dautzenberg FM, Dietrich K, Palchaudhuri MR, Spiess J., J Neurochem. October 1, 1997; 69 (4): 1640-9.
Background adaptation by Xenopus laevis: a model for studying neuronal information processing in the pituitary pars intermedia. , Roubos EW ., Comp Biochem Physiol A Physiol. November 1, 1997; 118 (3): 533-50.
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. , Dautzenberg FM, Wille S, Lohmann R, Spiess J., Proc Natl Acad Sci U S A. April 28, 1998; 95 (9): 4941-6.
Structure and function of the ovine type 1 corticotropin releasing factor receptor ( CRF1) and a carboxyl-terminal variant. , Myers DA, Trinh JV, Myers TR., Mol Cell Endocrinol. September 25, 1998; 144 (1-2): 21-35.
Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. , Wille S, Sydow S, Palchaudhuri MR, Spiess J, Dautzenberg FM., J Neurochem. January 1, 1999; 72 (1): 388-95.
Expression of salmon corticotropin-releasing hormone precursor gene in the preoptic nucleus in stressed rainbow trout. , Ando H, Hasegawa M, Ando J, Urano A., Gen Comp Endocrinol. January 1, 1999; 113 (1): 87-95.
The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. , Dautzenberg FM, Kilpatrick GJ, Wille S, Hauger RL., J Neurochem. August 1, 1999; 73 (2): 821-9.
Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. , Arai M, Assil IQ, Abou-Samra AB., Endocrinology. January 1, 2001; 142 (1): 446-54.
Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. , Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G., J Pharmacol Exp Ther. January 1, 2001; 296 (1): 113-20.
125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. , Higelin J, Py-Lang G, Paternoster C, Ellis GJ, Patel A, Dautzenberg FM., Neuropharmacology. January 1, 2001; 40 (1): 114-22.
Biochemical characterization and expression analysis of the Xenopus laevis corticotropin-releasing hormone binding protein. , Valverde RA, Seasholtz AF, Cortright DN, Denver RJ ., Mol Cell Endocrinol. February 28, 2001; 173 (1-2): 29-40.
Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish. , Pohl S, Darlison MG, Clarke WC, Lederis K, Richter D., Eur J Pharmacol. November 2, 2001; 430 (2-3): 193-202.
Five amino acids of the Xenopus laevis CRF ( corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart. , Dautzenberg FM, Higelin J, Brauns O, Butscha B, Hauger RL., Mol Pharmacol. May 1, 2002; 61 (5): 1132-9.
Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. , Seasholtz AF, Valverde RA, Denver RJ ., J Endocrinol. October 1, 2002; 175 (1): 89-97.
Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis. , Crespi EJ , Vaudry H, Denver RJ ., J Neuroendocrinol. March 1, 2004; 16 (3): 279-88.
Binding differences of human and amphibian corticotropin-releasing factor type 1 ( CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism. , Dautzenberg FM, Wille S., Regul Pept. May 15, 2004; 118 (3): 165-73.
Expression and hypophysiotropic actions of corticotropin-releasing factor in Xenopus laevis. , Boorse GC, Denver RJ ., Gen Comp Endocrinol. July 1, 2004; 137 (3): 272-82.
Regulation of pituitary thyrotropin gene expression during Xenopus metamorphosis: negative feedback is functional throughout metamorphosis. , Manzon RG, Denver RJ ., J Endocrinol. August 1, 2004; 182 (2): 273-85.
Cloning and tissue distribution of the chicken type 2 corticotropin-releasing hormone receptor. , de Groef B, Grommen SV, Mertens I, Schoofs L, Kühn ER, Darras VM., Gen Comp Endocrinol. August 1, 2004; 138 (1): 89-95.
Distribution and acute stressor-induced activation of corticotrophin-releasing hormone neurones in the central nervous system of Xenopus laevis. , Yao M, Westphal NJ, Denver RJ ., J Neuroendocrinol. November 1, 2004; 16 (11): 880-93.
Ontogeny of corticotropin-releasing factor effects on locomotion and foraging in the Western spadefoot toad (Spea hammondii). , Crespi EJ , Denver RJ ., Horm Behav. November 1, 2004; 46 (4): 399-410.
Opioid peptides, CRF, and urocortin in cerebrospinal fluid-contacting neurons in Xenopus laevis. , Calle M, Claassen IE, Veening JG, Kozicz T, Roubos EW , Barendregt HP., Ann N Y Acad Sci. April 1, 2005; 1040 249-52.
Evidence that urocortin I acts as a neurohormone to stimulate alpha MSH release in the toad Xenopus laevis. , Calle M, Corstens GJ, Wang L, Kozicz T, Denver RJ , Barendregt HP, Roubos EW ., Dev Biol. April 8, 2005; 1040 (1-2): 14-28.
Urocortins of the South African clawed frog, Xenopus laevis: conservation of structure and function in tetrapod evolution. , Boorse GC, Crespi EJ , Dautzenberg FM, Denver RJ ., Endocrinology. November 1, 2005; 146 (11): 4851-60.
Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. , Boorse GC, Denver RJ ., Gen Comp Endocrinol. March 1, 2006; 146 (1): 9-18.
Corticotropin-releasing factor is cytoprotective in Xenopus tadpole tail: coordination of ligand, receptor, and binding protein in tail muscle cell survival. , Boorse GC, Kholdani CA, Seasholtz AF, Denver RJ ., Endocrinology. March 1, 2006; 147 (3): 1498-507.
Effect of starvation on Fos and neuropeptide immunoreactivities in the brain and pituitary gland of Xenopus laevis. , Calle M, Kozicz T, van der Linden E, Desfeux A, Veening JG, Barendregt HP, Roubos EW ., Gen Comp Endocrinol. July 1, 2006; 147 (3): 237-46.
Localisation and physiological regulation of corticotrophin-releasing factor receptor 1 mRNA in the Xenopus laevis brain and pituitary gland. , Calle M, Jenks BG , Corstens GJ, Veening JG, Barendregt HP, Roubos EW ., J Neuroendocrinol. October 1, 2006; 18 (10): 797-805.
Structural and functional conservation of vertebrate corticotropin-releasing factor genes: evidence for a critical role for a conserved cyclic AMP response element. , Yao M, Stenzel-Poore M, Denver RJ ., Endocrinology. May 1, 2007; 148 (5): 2518-31.
A combined patch-clamp and electrorotation study of the voltage- and frequency-dependent membrane capacitance caused by structurally dissimilar lipophilic anions. , Zimmermann D, Kiesel M, Terpitz U, Zhou A, Reuss R, Kraus J, Schenk WA, Bamberg E, Sukhorukov VL., J Membr Biol. January 1, 2008; 221 (2): 107-21.
Brain distribution and evidence for both central and neurohormonal actions of cocaine- and amphetamine-regulated transcript peptide in Xenopus laevis. , Roubos EW , Lázár G, Calle M, Barendregt HP, Gaszner B, Kozicz T., J Comp Neurol. April 1, 2008; 507 (4): 1622-38.
Evolutionarily conserved glucocorticoid regulation of corticotropin-releasing factor expression. , Yao M, Schulkin J, Denver RJ ., Endocrinology. May 1, 2008; 149 (5): 2352-60.
Teratogenic effects of chronic treatment with corticosterone on tadpoles of Xenopus laevis. , Lorenz C, Opitz R, Lutz I, Kloas W ., Ann N Y Acad Sci. April 1, 2009; 1163 454-6.
The organization of CRF neuronal pathways in toads: Evidence that retinal afferents do not contribute significantly to tectal CRF content. , Carr JA, Lustgarten J, Ahmed N, Bergfeld N, Bulin SE, Shoukfeh O, Tripathy S., Brain Behav Evol. January 1, 2010; 76 (1): 71-86.